UPDATE: FDA Warns AGAINST Using Anti-Malaria Drug Hydroxychloroquine Touted By Trump
The malaria drugs hydroxychloroquine and chloroquine that we’re hailed by Donald Trump as a being ‘game-changer’ for treating COVID-19, is now getting negative feedback from the US Food and Drug Administration.
RELATED: Rita Wilson Says Chloroquine Gave Her & Tom Hanks ‘Extreme Side Effects’
This Friday, the FDA warned against using the drug after several reports of abnormal heart rhythms and rapid heart rates in patients who took the medication.
“The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin,’ the FDA wrote in a statement issued on Friday. The agency added, “We are also aware of increased use of these medicines through outpatient prescriptions. Therefore, we would like to remind health care professionals and patients of the known risks associated with both hydroxychloroquine and chloroquine.”
Now, what’s strange is that some patients claimed that the drug worked. A very small number reported the same. However, since then, much of the initial excitement surround hydroxychloroquine has died down.
Despite that, the agency said hydroxychloroquine can still be used in clinical trials or in some hospitalized patients. As the Daily Mail notes, It’s not immediately clear if any trials are in progress or planned trials will be halted based on the new guidance.
Press Play Below For More:
RELATED: Florida Man With Coronavirus Says Drug Touted By President Trump Saved His Life